Lintuzumab AC 225 is an Antibody Radio-Conjugate (ARC) comprised of the anti-CD33 monoclonal antibody lintuzumab labeled with the radioisotope actinium-225.
| SparkCures ID | 268 |
|---|---|
| Developed By | Actinium Pharmaceuticals |
| Generic Name | Lintuzumab AC 225 |
| Treatment Classifications |
|
| Treatment Targets |